Patients with history of opioid abuse dislike over dose of Acurox
Thursday, May 07, 2009 14:00 IST New Orleans, Louisiana
King Pharmaceuticals Inc and Acura Pharmaceuticals Inc presented the results from an oral abuse liability study of Acurox (oxycodone HCl/niacin) Tablets, AP-ADF-111 (Study 111)